KRT8 and breast carcinoma: We found that PRDM14 was frequently expressed by CK5+CK8– estrogen receptor-negative breast cancer cells, and that PRDM14 prevented reversal of HCC1937 cells to a stem-like phenotype, suggesting that PRDM14 maintains breast cancer cells in an undifferentiated state.